Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Common Equity: 2009-2025

Historic Common Equity for Pediatrix Medical (MD) over the last 17 years, with Q3 2025 value amounting to $890.7 million.

  • Pediatrix Medical's Common Equity rose 2159.4% to $890.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $890.7 million, marking a year-over-year increase of 2159.4%. This contributed to the annual value of $764.9 million for FY2024, which is 990.78% down from last year.
  • Per Pediatrix Medical's latest filing, its Common Equity stood at $890.7 million for Q3 2025, which was up 2159.4% from $833.8 million recorded in Q2 2025.
  • Over the past 5 years, Pediatrix Medical's Common Equity peaked at $968.0 million during Q3 2023, and registered a low of $706.5 million during Q2 2024.
  • For the 5-year period, Pediatrix Medical's Common Equity averaged around $843.9 million, with its median value being $849.1 million (2023).
  • As far as peak fluctuations go, Pediatrix Medical's Common Equity crashed by 4843.45% in 2021, and later soared by 2159.4% in 2025.
  • Pediatrix Medical's Common Equity (Quarter) stood at $896.7 million in 2021, then fell by 0.56% to $891.6 million in 2022, then decreased by 4.77% to $849.1 million in 2023, then decreased by 9.91% to $764.9 million in 2024, then rose by 16.44% to $890.7 million in 2025.
  • Its Common Equity stands at $890.7 million for Q3 2025, versus $833.8 million for Q2 2025 and $789.2 million for Q1 2025.